Pharmaceutical Technology Europe
Direct dosing APIs during R&D studies can reduce the overall testing time of a drug candidate by allowing for a greater throughput of compounds through the R&D department.
David Edwards
Advertisement
David Edwards is Director of Pharmaceutical Technology at Capsugel.
Articles by David Edwards
Advertisement
Latest Updated Articles
Improving R&D with API microdosingSeptember 1st 2011
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5